Главная
Study mode:
on
1
Intro
2
Early Intervention
3
Risk of Therapies
4
Crohns Disease
5
Diagnostic Delay
6
Early Intervention with biologics
7
Real World Prescriptions
8
Predicting Prognosis
9
CDPath
10
Target
11
Summary
12
stride targets
13
stride 2 update
14
quality of life
15
biomarkers
16
outcomes
17
disease modifying
18
therapeutic drug monitoring
19
proactive dose escalation
20
proactive dose optimization
21
induction
22
maintenance efficacy
23
maintenance arm
24
personalizing pk
25
future of pk
26
prognostic markers
Description:
Explore a comprehensive lecture on managing Inflammatory Bowel Disease (IBD) with precision, delivered by Dr. Marla Dubinsky at the 9th Annual UCLA-Mellinkoff Gastroenterology and Hepatology Symposium. Delve into crucial topics such as early intervention strategies, risk assessment of therapies, and diagnostic challenges in Crohn's disease. Examine the importance of timely biological treatments and real-world prescription practices. Gain insights into predicting prognosis using tools like CDPath and Target. Analyze the STRIDE targets and their updates, focusing on quality of life improvements and biomarker utilization. Investigate disease-modifying approaches, therapeutic drug monitoring, and proactive dose optimization for both induction and maintenance phases. Learn about personalizing pharmacokinetics and explore the future of prognostic markers in IBD management.

Managing IBD with Precision - Marla Dubinsky, MD - UCLA-Mellinkoff GI & Hep Symposium 2021

University of California, Los Angeles
Add to list
0:00 / 0:00